PT  - JOURNAL ARTICLE
AU  - Zeinab Ghorbanoghli
AU  - Mariëtte van Kouwen
AU  - Birgitta Versluys
AU  - Delphine Bonnet
AU  - Christine Devalck
AU  - Julie Tinat
AU  - Danuta Januszkiewicz-Lewandowska
AU  - Consuelo Calvino Costas
AU  - Edouard Cottereau
AU  - James C H Hardwick
AU  - Katharina Wimmer
AU  - Laurence Brugieres
AU  - Chrystelle Colas
AU  - Hans F A Vasen
TI  - High yield of surveillance in patients diagnosed with constitutional mismatch repair deficiency
AID  - 10.1136/jmg-2022-108829
DP  - 2022 Nov 21
TA  - Journal of Medical Genetics
PG  - jmg-2022-108829
4099  - http://jmg.bmj.com/content/early/2022/11/21/jmg-2022-108829.short
4100  - http://jmg.bmj.com/content/early/2022/11/21/jmg-2022-108829.full
AB  - Background Constitutional mismatch repair deficiency (CMMRD) is a rare autosomal recessively inherited syndrome that is caused by biallelic pathogenic variants of the mismatch repair genes. It is characterised by the development of multiple tumours in the first and second decade of life including brain, gastrointestinal and haematological tumours often resulting in early death. In order to improve the prognosis of these patients, the European collaborative group ‘care for CMMRD’ developed a surveillance programme in 2014 and established a registry of patients with CMMRD in Paris. The aim of the study was to evaluate the outcome of this programme.Methods Twenty-two patients with a definitive diagnosis of CMMRD and with at least one follow-up study were selected from the registry. Medical data on the outcome of surveillance were collected from these patients.Results During a mean follow-up of 4 years, the programme detected eight malignant tumours including three brain tumours, three upper gastrointestinal cancers and two colorectal cancers. Most tumours could successfully be treated. In addition, many adenomas were detected in the duodenum, and colorectum and subsequently removed. Seven patients developed a symptomatic malignancy, including two brain tumours, one small bowel cancer and four haematological malignancies. At the end of the follow-up, 16 out of 22 patients (73%) who participated in the surveillance programme were still alive.Conclusion The study suggests a beneficial effect of surveillance of the digestive tract and brains.All data relevant to the study are included in the article or uploaded as supplementary information.